Fitness for 5 genes in Pontibacter actiniarum KMM 6156, DSM 19842

Add gene:

Number of genes on each side:  

Top 30 experiments (either direction), sorted by average fitness

Or view all 112 experiments or choose conditions or try the comparative fitness browser

500 ntCA264_14500 and CA264_14505 are separated by 52 nucleotidesCA264_14505 and CA264_14510 overlap by 8 nucleotidesCA264_14510 and CA264_14515 are separated by 76 nucleotidesCA264_14515 and CA264_14520 are separated by 842 nucleotides CA264_14500: CA264_14500 - nucleotidyltransferase, at 3,402,141 to 3,403,148 _14500 CA264_14505: CA264_14505 - hypothetical protein, at 3,403,201 to 3,404,910 _14505 CA264_14510: CA264_14510 - hypothetical protein, at 3,404,903 to 3,405,655 _14510 CA264_14515: CA264_14515 - peptidase M23, at 3,405,732 to 3,406,967 _14515 CA264_14520: CA264_14520 - twin-arginine translocase TatA/TatE family subunit, at 3,407,810 to 3,408,022 _14520
Group Condition CA264_14500 CA264_14505 CA264_14510 CA264_14515 CA264_14520
stress m.b. Carbenicillin 0.0015 mg/ml N.D. -1.1 -3.6 -1.6 N.D.
stress m.b. Carbenicillin 0.0015 mg/ml N.D. -0.8 -2.6 -0.7 N.D.
stress m.b. Vancomycin 0.016 mg/ml N.D. -0.0 -0.0 -2.6 N.D.
stress m.b. Vancomycin 0.016 mg/ml N.D. -0.1 -0.1 -2.0 N.D.
stress m.b. Nickel (II) chloride 1 mM N.D. -0.3 -1.1 -0.5 N.D.
stress m.b. Ceftazidime 0.001 mg/ml N.D. -0.4 -2.3 +0.9 N.D.
stress m.b. Ceftazidime 0.001 mg/ml N.D. -0.2 -2.4 +1.0 N.D.
stress m.b. Vancomycin 0.008 mg/ml N.D. -0.0 -0.4 -0.9 N.D.
stress m.b. Doxycycline hyclate 0.008 mg/ml N.D. +0.2 +0.3 -1.6 N.D.
stress m.b. A22 0.04 mg/ml N.D. +0.2 -1.5 +0.2 N.D.
stress m.b. Doxycycline hyclate 0.004 mg/ml N.D. +0.3 -0.3 -1.0 N.D.
stress m.b. A22 0.04 mg/ml N.D. +0.0 -1.9 +0.9 N.D.
stress m.b. Doxycycline hyclate 0.008 mg/ml N.D. +0.1 +0.3 -1.2 N.D.
stress m.b. Tetracycline 0.003 mg/ml N.D. +0.3 +0.1 -1.1 N.D.
stress m.b. Thallium(I) acetate 0.0025 mg/ml N.D. +0.4 -1.2 +0.1 N.D.
stress m.b. Thallium(I) acetate 0.0025 mg/ml N.D. +0.5 -0.9 +0.1 N.D.
stress m.b. Cisplatin 0.025 mg/ml N.D. +0.1 -1.1 +1.1 N.D.
stress m.b. Cisplatin 0.025 mg/ml N.D. +0.1 -0.5 +1.1 N.D.
stress m.b. Spectinomycin 0.08 mg/ml N.D. +0.9 +0.3 -0.2 N.D.
stress m.b. Ceftazidime 0.0005 mg/ml N.D. -0.0 +0.6 +0.7 N.D.
stress m.b. Ceftazidime 0.0005 mg/ml N.D. -0.1 +0.6 +0.7 N.D.
stress m.b. Thallium(I) acetate 0.001 mg/ml N.D. -0.3 -0.3 +1.9 N.D.
stress m.b. Thallium(I) acetate 0.001 mg/ml N.D. -0.2 -0.3 +1.8 N.D.
stress m.b. Carbenicillin 0.0004 mg/ml N.D. -0.5 +1.1 +0.7 N.D.
stress m.b. Carbenicillin 0.0004 mg/ml N.D. -0.3 +1.0 +1.0 N.D.
stress m.b. copper (II) chloride 0.16 mM N.D. +1.0 +1.6 -0.4 N.D.
stress m.b. copper (II) chloride 0.16 mM N.D. +1.0 +1.9 -0.1 N.D.
stress m.b. Cephalothin 0.005 mg/ml N.D. -0.5 +1.9 +1.9 N.D.
stress m.b. Cephalothin 0.005 mg/ml N.D. -0.5 +2.1 +2.3 N.D.
stress m.b. Cisplatin 0.035 mg/ml N.D. +0.3 +0.1 +3.9 N.D.
remove
CA264_14500
plot		 remove
CA264_14505
plot		 remove
CA264_14510		 remove
CA264_14515
plot		 remove
CA264_14520
plot